TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 38 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,302 | -92.4% | 1,054 | -86.8% | 0.00% | -100.0% |
| Q2 2023 | $70,097 | +162916.3% | 8,011 | +119.5% | 0.00% | +100.0% |
| Q1 2023 | $43 | -24.6% | 3,650 | -34.1% | 0.00% | -50.0% |
| Q4 2022 | $57 | -99.9% | 5,539 | -16.1% | 0.00% | +100.0% |
| Q3 2022 | $39,000 | +50.0% | 6,601 | -37.0% | 0.00% | 0.0% |
| Q2 2022 | $26,000 | +136.4% | 10,480 | +194.7% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 3,556 | +130.5% | 0.00% | – |
| Q4 2021 | $11,000 | +37.5% | 1,543 | +103.3% | 0.00% | – |
| Q3 2021 | $8,000 | -42.9% | 759 | -35.7% | 0.00% | – |
| Q2 2021 | $14,000 | 0.0% | 1,180 | +92.2% | 0.00% | – |
| Q1 2021 | $14,000 | – | 614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |